Lumos Pharma SG&A Expense (TTM) Insights

Lumos Pharma Inc (LUMO)

2.286 +0.03 (+1.55%) USD | NASDAQ | Jun 28, 16:00

2.25 -0.04 (-1.57%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2011. Upgrade now.

Date	Value
March 31, 2024	20.35M
December 31, 2023	20.93M
September 30, 2023	21.24M
June 30, 2023	21.26M
March 31, 2023	20.06M
December 31, 2022	19.33M
September 30, 2022	18.27M
June 30, 2022	17.74M
March 31, 2022	15.00M
December 31, 2021	15.33M
September 30, 2021	16.53M
June 30, 2021	18.30M
March 31, 2021	17.89M
December 31, 2020	17.26M
September 30, 2020	13.89M
June 30, 2020	10.23M
March 31, 2020	6.795M
December 31, 2019	4.147M
September 30, 2019	8.319M
June 30, 2019	14.41M
March 31, 2019	21.61M
December 31, 2018	29.22M
September 30, 2018	30.48M
June 30, 2018	30.80M
March 31, 2018	31.78M

Date	Value
December 31, 2017	31.73M
September 30, 2017	32.22M
June 30, 2017	32.06M
March 31, 2017	32.30M
December 31, 2016	33.23M
September 30, 2016	33.72M
June 30, 2016	33.36M
March 31, 2016	31.49M
December 31, 2015	30.69M
September 30, 2015	31.29M
June 30, 2015	28.84M
March 31, 2015	24.44M
December 31, 2014	19.33M
September 30, 2014	14.04M
June 30, 2014	11.37M
March 31, 2014	10.77M
December 31, 2013	9.521M
September 30, 2013	8.625M
June 30, 2013	7.764M
March 31, 2013	7.651M
December 31, 2012	7.108M
September 30, 2012	7.131M
June 30, 2012	6.836M
March 31, 2012	5.821M
December 31, 2011	5.679M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

4.147M

Minimum

Dec 2019

21.26M

Maximum

Jun 2023

15.94M

Average

17.74M

Median

Jun 2022

SG&A Expense (TTM) Benchmarks